Sort
23,748 grants matching “melanoma”
Obesity Affects Immunity to Kidney Cancer
$285,104Lyse A Norian · University Of Alabama At Birmingham · R01 · FY2018 · CA
Apoptosis in Melanoma Progression and Chemoresistance
$285,035Maria S Soengas · University Of Michigan At Ann Arbor · R01 · FY2007 · CA
Tumor exosomes as agents of genetic change
$285,005Xandra Owens Breakefield · Massachusetts General Hospital · R01 · FY2011 · CA
Light-responsive ruthenium compounds for applications in disease
$285,004Edith C Glazer · University Of Kentucky · R01 · FY2016 · GM
Keratinocyte responses to vascular endothelial growth factor in carcinogenesis
$285,000Traci A Wilgus · Ohio State University · R01 · FY2009 · CA
Keratinocyte responses to vascular endothelial growth factor in carcinogenesis
$285,000Traci A Wilgus · Ohio State University · R01 · FY2008 · CA
Enantioselective Functionalizations of Azomethines and Alkenes
$284,907Jeffrey Nicholas Johnston · Vanderbilt University · R01 · FY2016 · GM
Clinical Development of anti-OX40 and OX40L
$284,860Brendan D Curti · Providence Portland Medical Center · R01 · FY2006 · CA
Regulation of tumor promotion by RasGRP1
$284,811Patricia S Lorenzo · University Of Hawaii At Manoa · R01 · FY2011 · CA
Lipid programs in melanocyte transformation
$284,811Michael H. Overholtzer · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Project 1
$284,803Kunle O Odunsi · Roswell Park Cancer Institute Corp · P50 · FY2022 · CA
Biomarkers of the Proinflammatory Response and Elements of Immune Suppression
$284,759Ahmad A. Tarhini · University Of Pittsburgh At Pittsburgh · P50 · FY2014 · CA
Elucidating the Function of the NF1 Tumor Suppressor and its Effector Pathways in
$284,709Karen M Cichowski · Brigham And Women'S Hospital · R01 · FY2012 · CA
Peptide Vaccination Targeting Tumor-Specific IDH1R132H Mutation for Brain Tumors
$284,697John H Sampson · Duke University · P50 · FY2016 · CA
Enantioselective Functionalizations of Azomethines and Alkenes
$284,639Jeffrey Nicholas Johnston · Vanderbilt University · R01 · FY2017 · GM
IDENTIFICATION OF GLYCOMIC ALTERATIONS DURING MELANOMA METASTASIS
$284,597New York University · · FY2012 · Department of the Army
ADHESION AND ERK SIGNALING IN MELANOMA
$284,589Andrew E Aplin · Thomas Jefferson University · R01 · FY2013 · GM
Administration and Clinical Trials
$284,583Jeffrey S Weber · H. Lee Moffitt Cancer Ctr & Res Inst · P50 · FY2017 · CA
An RNA Sensor for Detection of Circulating Tumor Cells
$284,503Gary A Clawson · Pennsylvania State Univ Hershey Med Ctr · R33 · FY2007 · CA
An RNA Sensor for Detection of Circulating Tumor Cells
$284,503Gary A Clawson · Pennsylvania State Univ Hershey Med Ctr · R33 · FY2008 · CA
Immunomodulation in melanoma therapy
$284,441Noah A Craft · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · R01 · FY2008 · CA
Elucidating the Function of the NF1 tumor suppressor and its effector pathways in
$284,401Karen M Cichowski · Brigham And Women'S Hospital · R01 · FY2011 · CA
ADJUVANT EFFECTS OF ALPHA GALACTOSYLCERAMIDES
$284,400Princeton University · R01 · FY2000 · CA
Molecular mechanisms behind the voltage sensing phosphatase signaling
$284,400Susy C Kohout · Montana State University - Bozeman · R01 · FY2015 · GM
ADJUVANT EFFECTS OF ALPHA GALACTOSYLCERAMIDES
$284,400Princeton University · R01 · FY2001 · CA